2025 / 01

Next Paper
DOI: 10.24075/brsmu.2025.001
Copyright: © 2025 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

REVIEW

miRNA biogenesis and functioning: 30 years since their discovery

Pisklova MV1, Baulina NM1,2, Matveeva NA1,2, Favorova OO1,2
About authors

1 Chazov National Medical Research Center of Cardiology, Moscow, Russia

2 Pirogov Russian National Research Medical University

Correspondence should be addressed: Maria V. Pisklova
Akademika Chazova, 15А, Moscow, 121552, Russia; ur.liam@airam_avolksip

About paper

Funding: the study was conducted within the framework of the State Assignment of the Chazov National Medical Research Center of Cardiology (No. 124020200013-3).

Author contribution: Pisklova MV — literature data acquisition, analysis and systematization, planning and writing the manuscript draft, selecting drawings; Baulina NM, Favorova OO — planning, manuscript structuring, editing; Matveeva NA — literature data analysis and systematization, manuscript writing.

Received: 2024-11-24 Accepted: 2024-12-20 Published online: 2025-01-28
|
  1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75 (5): 843–54. DOI:10.1016/0092-8674(93)90529-Y
  2. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993; 75 (5): 855–62. DOI: 10.1016/0092-8674(93)90530-4.
  3. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000; 403 (6772): 901–06. DOI: 10.1038/35002607.
  4. Moran Y, Agron M, Praher D, Technau U. The evolutionary origin of plant and animal microRNAs. Nat Ecol Evol. 2017; 1 (3): 27. DOI: 10.1038/s41559-016-0027.
  5. Dexheimer PJ, Cochella L. MicroRNAs: From Mechanism to Organism. Front Cell Dev Biol. 2020; 8: 409. DOI: 10.3389/fcell.2020.00409.
  6. Bhaskaran M, Mohan M. MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease. Vet pathol. 2013; 51 (4): 759. DOI: 10.1177/0300985813502820.
  7. O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne). 2018; 9: 402. DOI: 10.3389/fendo.2018.00402.
  8. Liu N, Okamura K, Tyler DM, Phillips MD, Chung WJ, Lai EC. The evolution and functional diversification of animal microRNA genes. Cell Res. 2008; 18 (10): 985. DOI: 10.1038/cr.2008.278.
  9. Abdelfattah AM, Park C, Choi MY. Update on non-canonical microRNAs. Biomol Concepts. 2014; 5 (4): 275. DOI: 10.1515/bmc-2014-0012.
  10. Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019; 20 (1): 5–20. DOI: 10.1038/s41580-018-0059-1.
  11. Yang JS, Lai EC. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell. 2011; 43 (6): 892–903. DOI: 10.1016/j.molcel.2011.07.024.
  12. Medley JC, Panzade G, Zinovyeva AY. microRNA strand selection: Unwinding the rules. Wiley Interdiscip Rev RNA. 2021; 12 (3): e1627. DOI: 10.1002/wrna.1627.
  13. Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015; 4: e05005. DOI: 10.7554/eLife.05005.
  14. Broughton JP, Lovci MT, Huang JL, Yeo GW, Pasquinelli AE. Pairing beyond the Seed Supports MicroRNA Targeting Specificity. Mol Diseases. Avicenna J Med Biotechnol. 2010; 2 (4): 161.
  15. Pratt AJ, MacRae IJ. The RNA-induced Silencing Complex: A Versatile Gene-silencing Machine. J Biol Chem. 2009; 284 (27): 17897. DOI:10.1074/jbc.R900012200.
  16. Iwakawa HO, Tomari Y. Life of RISC: Formation, action, and degradation of RNA-induced silencing complex. Mol Cell. 2022; 82 (1): 30–43. DOI: 10.1016/j.molcel.2021.11.026.
  17. Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019; 20 (1): 21–37. DOI: 10.1038/s41580-018-0045-7.
  18. Wong JJL, Ritchie W, Gao D, Lau KA, Gonzalez M, Choudhary A, et al. Identification of nuclear-enriched miRNAs during mouse granulopoiesis. J Hematol Oncol. 2014; 7: 42. DOI: 10.1186/1756-8722-7-42.
  19. Hu X, Yin G, Zhang Y, Zhu L, Huang H, Lv K. Recent advances in the functional explorations of nuclear microRNAs. Front Immunol. 2023; 14: 1097491. DOI: 10.3389/fimmu.2023.1097491.
  20. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012; 110 (3): 483–95. DOI: 10.1161/CIRCRESAHA.111.247452.
  21. Ardekani AM, Naeini MM. The Role of MicroRNAs in Human Diseases. Avicenna J Med Biotechnol. 2010; 2 (4): 161.
  22. Paul P, Chakraborty A, Sarkar D, Langthasa M, Rahman M, Bari M, et al. Interplay between miRNAs and human diseases. J Cell Physiol. 2018; 233 (3): 2007–18. DOI: 10.1002/jcp.25854.
  23. Zhu JJ, Liu YF, Zhang YP, Zhao CR, Yao WJ, Li YS, et al. VAMP3 and SNAP23 mediate the disturbed flow-induced endothelial microRNA secretion and smooth muscle hyperplasia. Proc Natl Acad Sci U S A. 2017; 114 (31): 8271. DOI: 10.1073/pnas.1700561114.
  24. Yang M, Chen J, Su F, Yu B, Su F, Lin L, et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer. 2011; 10: 117. DOI: 10.1186/1476-4598-10-117.
  25. Ho PTB, Clark IM, Le LTT. MicroRNA-Based Diagnosis and Therapy. Int J Mol Sci. 2022; 23 (13): 7167. DOI: 10.3390/ijms23137167.
  26. Backes C, Meese E, Keller A. Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects. Mol Diagn Ther. 2016; 20 (6): 509–18. DOI: 10.1007/s40291-016-0221-4.
  27. Solé C, Moliné T, Vidal M, Ordi-Ros J, Cortés-Hernández J. An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis. Cells. 2019; 8 (8): 773. DOI: 10.3390/cells8080773.
  28. Beg MS, Brenner AJ, Sachdev J, Borad M, Kang YK, Stoudemire J, et al. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest new drugs. 2016; 35 (2): 180. DOI: 10.1007/s10637-016-0407-y.
  29. Seyhan AA. Trials and Tribulations of MicroRNA Therapeutics. Int J Mol Sci. 2024; 25 (3): 1469. DOI: 10.3390/ijms25031469.